FranΓ§aisπ See the interactive version (live chart) β
For Macerich, we replayed every analyst price target of the past 12 months and measured the real outcome: 38% were profitable, average return +1% (87 calls). At 3 months: +4% average return (48% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 12 | 67% | +3% |
| Deutsche Bank | 9 | 33% | +3% |
| Piper Sandler | 9 | 33% | +5% |
| Mizuho | 9 | 44% | +6% |
| Goldman Sachs | 7 | 0% | -13% |
The analyst consensus on Macerich (MAC) is "Hold" (14 bullish, 3 bearish calls over 12 months). This is not advice: historically, 38% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $26.00 (+9% vs $23.92), ranging from $19.00 to $30.00 (13 analysts).
Over 1 year, 38% of analyst targets on Macerich were profitable, for an average return of +1% (across 87 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $26.00 within 12 months, i.e. +9% vs the current price. The most bullish targets $30.00, the most cautious $19.00.
Note: analyst targets are 12-month (median $26.00, +9%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (38%), and the stock's past trajectory.
Detailed valuation data for Macerich is available in the interactive analysis.
π See the full interactive analysis of Macerich β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.